Previous close | 6.00 |
Open | 5.80 |
Bid | 1.90 |
Ask | 3.60 |
Strike | 35.00 |
Expiry date | 2024-12-20 |
Day's range | 5.80 - 6.00 |
Contract range | N/A |
Volume | |
Open interest | 254 |
LBPH stock soars 52% on announcing that it is set to be acquired by Lundbeck for a total consideration of $2.6 billion to bolster the latter's neuro pipeline.
ITCI is seeing strong Caplyta sales, driven by a high prescription rate. However, its heavy reliance on the drug's sales for growth is concerning.
Xenon Pharmaceuticals Inc (XENE) showcases robust financial health and promising developments in epilepsy and depression treatments.